Marimed (MRMD) Change in Account Payables (2011 - 2026)
Marimed's (MRMD) quarterly Change in Account Payables came in at $523000.0 in Q1 2026, up 508.14% year-on-year from $86000.0 in Q1 2025, and down 85.19% on a QoQ basis from $3.5 million in Q4 2025.
Marimed (MRMD) Change in Account Payables (2011 - 2026) Analysis & Trends
Marimed (MRMD) has 16 years of Change in Account Payables data on file, last reported at $523000.0 in Q1 2026.
- On a quarterly basis, Change in Account Payables rose 508.14% year-over-year to $523000.0 in Q1 2026; TTM through Mar 2026 was $1.3 million, a 56.53% decrease from a year earlier, with the FY2025 full-year figure at $841000.0, down 79.92% from the prior year.
- Change in Account Payables for Q1 2026 stood at $523000.0, down from $3.5 million in the prior quarter.
- Over the last five years, Change in Account Payables for MRMD reached as high as $3.5 million in Q4 2025 and fell as low as -$2.8 million in Q2 2025.
- Historically, Change in Account Payables has averaged $526705.9 across 5 years, with a median of $507000.0 in 2023.
- Across the five-year window, Change in Account Payables tumbled 278.92% in 2022 and soared 11134.38% in 2025, its largest moves.
- Year by year, Change in Account Payables stood at -$1.3 million in 2022, then surged by 137.7% to $507000.0 in 2023, then plunged by 106.31% to -$32000.0 in 2024, then surged by 11134.38% to $3.5 million in 2025, then slumped by 85.19% to $523000.0 in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were $523000.0 in Q1 2026, $3.5 million in Q4 2025, and $23000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Marimed | 23.85 Mn | 14.02 Mn | 15.28 Mn | 523,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 523,000.00 |
| Mar 31, 2026 | 523,000.00 |
| Dec 31, 2025 | 3.53 Mn |
| Dec 31, 2025 | 3.53 Mn |
| Sep 30, 2025 | 23,000.00 |
| Sep 30, 2025 | 23,000.00 |
| Jun 30, 2025 | -2.80 Mn |
| Jun 30, 2025 | -2.80 Mn |
| Mar 31, 2025 | 86,000.00 |
| Mar 31, 2025 | 86,000.00 |
| Dec 31, 2024 | -32,000.00 |
| Dec 31, 2024 | -32,000.00 |
| Sep 30, 2024 | 613,000.00 |
| Sep 30, 2024 | 613,000.00 |
| Jun 30, 2024 | 2.27 Mn |
| Jun 30, 2024 | 2.27 Mn |
| Mar 31, 2024 | 1.33 Mn |
| Mar 31, 2024 | 1.33 Mn |
| Dec 31, 2023 | 507,000.00 |
| Dec 31, 2023 | 507,000.00 |